Dohn, L.H. et al. 2010. Short time infusion of bevacizumab in combination with 5FU-based chemotherapy as first-line therapy in a non-selective patient group with metastatic colorectal cancer. Acta Oncologica. 49, 3 (Jan. 2010), 395–396. DOI:https://doi.org/10.3109/02841860903428184.